Expres2ion Biotech

Financial Calendar

• 17/11/22

  Interim report, Q3 2022

• 09/02/23

  Year-end report, 2022

Latest press releases

ExpreS2ion publishes investor video presentation

27-09-2022 Non-regulatory pressrelease

Hørsholm, Denmark, September 27, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a filmed company presentation by CEO Bent U. Frandsen at Aktiedagen Lund in which he presents provides an update on ExpreS2ion’s powerful technology platform for vaccine development, pipeline projects, and key financial figures, is now available on the…

Read more

Pareto publishes research report setting price target of SEK 25 per share as new analyst assumes coverage

22-09-2022 Non-regulatory pressrelease

Hørsholm, Denmark, September 22, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that Pareto Securities has published a new research report on ExpreS2ion in September in which a new analyst, Marietta Miemietz, assumes coverage of the Company. 

Read more

View all